Collection of Stool From Healthy Donors for the ex Vivo Study of Shifts of Microbiome Induced by Dairy Phages and Antibiotics: a Model of Bacteria/Host Interaction (DAIRY-SHAPE)
NCT07212400 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4
Last updated 2026-01-13
Summary
The gut microbiota plays a crucial role in health through its involvement in pathogen defense, immune regulation, and nutrient digestion. Microbiota diversity is essential to maintain these functions, and disturbances caused by antibiotic intake or extreme diets can lead to an imbalance (dysbiosis), which is often described as being implicated in numerous diseases as well as in the proliferation of antibiotic-resistant pathogens.
The microbiota is defined as the community of microorganisms inhabiting the intestine, including bacteria, viruses, and bacteriophages (phages). These phages, through their ability to destroy the bacteria they infect, play an important role in regulating bacterial populations and could therefore be essential for restoring balance and diversity in the gut.
Probiotics, foods that support the microbiota such as dairy products, are of particular interest because the specific interactions between phages and bacteria within these food microbiomes could stimulate microbiota restoration.
This study aims to evaluate the effectiveness of phage-based functional foods in restoring intestinal homeostasis and, by extension, improving human health. It will serve as a model to examine how phages present in foods, particularly dairy products, influence gut microbial diversity and to determine whether these phages promote recovery after antibiotic-induced disturbances.
Conditions
- General Population (no Specific Condition or Disease)
Sponsors & Collaborators
-
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
lead OTHER
Principal Investigators
-
Eugen PFEIFER, Dr. · Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-10-16
- Primary Completion
- 2025-11-16
- Completion
- 2028-11-16
Countries
- France
Study Locations
More Related Trials
-
Sampling of Human Microbiota in Order to Test, on a Mouse Model, Individualized Intervention Strategies During Aging
NCT04753580 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Influence of Diet on GI Health
NCT04783142 ·Status: COMPLETED ·Phase: NA
-
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
NCT07250724 ·Status: RECRUITING
-
Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli
NCT02541695 ·Status: COMPLETED ·Phase: NA
-
Clostridioides Difficile Controlled Human Infection Model
NCT06702345 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
NCT04679324 ·Status: WITHDRAWN
-
Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults
NCT01230957 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity
NCT00772954 ·Status: TERMINATED ·Phase: PHASE1
-
Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and Stool
NCT04067440 ·Status: COMPLETED
-
A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.
NCT06948461 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
LMN-201 for Prevention of C. Difficile Infection Recurrence
NCT05330182 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
High-fat Diet (HFD) and Small Intestinal Microbiome
NCT07019142 ·Status: COMPLETED ·Phase: NA
-
The Impact of Food on Gut Microbiome Composition - a Clinical Trial Determining the Influence of Diet in Gut Microbiome Colonisation and Host Health
NCT05986955 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Placebo Controlled Study of Fecal Microbiota Transplant (FMT) for a First or Second Episode of C. Difficile Infection in Adults Using a Frozen Encapsulated Inoculum
NCT02343328 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers
NCT00127803 ·Status: COMPLETED ·Phase: PHASE1
-
Longitudinal Study of the Human Intestinal Microbiome
NCT00832286 ·Status: COMPLETED ·Phase: PHASE1
-
The GRAFT Study: Gut RecolonizAtion by Fecal Transplantation
NCT03621657 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
NCT07282665 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Stool Microbiome Using HyGIeaCare Prep
NCT04264923 ·Status: COMPLETED ·Phase: NA
-
Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19.
NCT05107245 ·Status: COMPLETED
-
Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization
NCT07106580 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection
NCT01887912 ·Status: TERMINATED ·Phase: PHASE3
-
Controlled Human Infection Model Challenge/Rechallenge
NCT04992520 ·Status: COMPLETED ·Phase: PHASE1
-
Fecal Microbiota Transplantation for Treatment of Gastrointestinal Dysbiosis or Clearance of ARO
NCT03834051 ·Status: TERMINATED ·Phase: NA
-
Interaction Between Non-typhoid Salmonella, Host Microbiota, and Immune System During Acute Infection and Remission
NCT03494101 ·Status: UNKNOWN